Twelve per cent of 6142 eyes treated for neovascular age-related macular degeneration (nAMD) presented with low visual outcome within 2 years. Analysis from the Swedish Macula Registry (SMR)

Research output: Contribution to journalArticlepeer-review

Filter
Doctoral Thesis (compilation)

Search results